Trial Profile
ASSESSMENT OF CELLULAR INFLAMMATION FOLLOWING ACUTE MYOCARDIAL INFARCTION Application Of Ultrasmall Superparamagnetic Particles Of Iron Oxide
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Inflammation; Myocardial disorders; Myocardial ischaemia
- Focus Diagnostic use
- Acronyms IRNMAN
- 04 Dec 2013 New trial record